Rituximab in thrombotic microangiopathy: Response to Castagna et al [5]

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 166-167

  Au, Wing Yan ^a   Lie, Albert K W ^a   Kwong, Yok Lam ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Haematopoietic stem cell transplantation; Rituximab; Thrombotic microangiopathy

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

DISEASE COURSE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MYCOSIS; PLASMAPHERESIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 34548591631     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06768.x     Document Type: Letter

References (3)

1. Au, W.Y., Ma, E.S., Lee, T.L., Ha, S.Y., Fung, A.T., Lie, A.K. Kwong, Y.L. (2007) Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. British Journal of Haematology, 137, 475 478.
2. Ho, V.T., Cutler, C., Carter, S., Martin, P., Adams, R., Horowitz, M., Ferrara, J., Soiffer, R. Giralt, S. (2005) Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 571 575.
3. Peyvandi, F., Siboni, S.M., Lambertenghi Deliliers, D., Lavoretano, S., De Fazio, N., Moroni, B., Lambertenghi Deliliers, G. Mannuccio Mannucci, P. (2006) Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. British Journal of Haematology, 134, 187 195.